Thermo Fisher Scientific | Les Charges D'Exploitation



Operating Expenses Changement Date
Abbott USD 8.7B 363M 2025-03
Agilent USD 1.31B 12M 2025-01
Becton, Dickinson and Co. USD 4.72B 74M 2024-12
Bio Techne USD 249.61M 141K 2024-12
Bio-Rad Laboratories USD 609.1M 23.84M 2024-12
Boston Scientific USD 3.89B 410M 2024-12
Bruker USD 915.5M 119.2M 2024-12
Charles River Laboratories USD 1.17B 277.88M 2024-12
Danaher USD 4.46B 655M 2025-03
Dentsply International USD 1.41B 1000K 2024-12
Edwards Lifesciences USD 1.07B 69.4M 2024-12
Exact Sciences USD 1.59B 841.72M 2024-12
General Electric USD 7.99B 732M 2025-03
Henry Schein USD 3.04B 19M 2024-12
Hologic USD 792M 34M 2024-12
Illumina USD 929M 590M 2024-12
Intuitive Surgical USD 1.68B 3.3M 2025-03
IQVIA Holdings USD 3.33B 14M 2024-12
Laboratory Of America USD 3.11B 85M 2024-12
Medtronic USD 6.65B 162M 2025-01
Mettler Toledo International USD 730.58M 884.93M 2024-12
Myriad Genetics USD 249.6M 16.3M 2024-12
Olympus JPY 212.93B 16.77B 2024-12
Patterson Companies USD 1.53B 109.77M 2025-01
Quest Diagnostics USD 2.31B 46M 2025-03
Repligen USD 204.05M 41.58M 2024-12
Revvity USD 610.62M 24.72M 2024-12
Stryker USD 5.86B 1.45B 2024-12
Thermo Fisher Scientific USD 9.38B 619M 2024-12
Veracyte USD 114.46M 10.61M 2024-12
Waters USD 580.45M 51.28M 2024-12
Zimmer Biomet Holdings USD 1.63B 89.5M 2024-12



Thermo Fisher Scientific Les Charges D'Exploitation - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Apr 2025.